Drugs interactions for

  • 247 Major drug interactions (including ingredients like Abametapir, Abatacept, Adalimumab)
  • 180 Moderate drug interactions (including ingredients like Abemaciclib, Acetylsalicylic acid, Acyclovir)
  • 394 Minor drug interactions (including ingredients like Abacavir, Aceclofenac, Acetaminophen)
821 interactions for
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and .
Abametapir
The serum concentration of Baricitinib can be increased when it is combined with Abametapir.
Abatacept
The risk or severity of adverse effects can be increased when Abatacept is combined with Baricitinib.
Adalimumab
The risk or severity of adverse effects can be increased when Adalimumab is combined with Baricitinib.
Adenovirus type 7 vaccine live
The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Baricitinib.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Baricitinib.
Alemtuzumab
The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Baricitinib.
Amiodarone
The metabolism of Baricitinib can be decreased when combined with Amiodarone.
Anakinra
The risk or severity of adverse effects can be increased when Anakinra is combined with Baricitinib.
Anifrolumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Anifrolumab.
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Baricitinib.
Antithymocyte immunoglobulin (rabbit)
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Baricitinib.
Apremilast
The risk or severity of adverse effects can be increased when Apremilast is combined with Baricitinib.
Arsenic trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Baricitinib.
Atazanavir
The metabolism of Baricitinib can be decreased when combined with Atazanavir.
Avacincaptad pegol
The risk or severity of adverse effects can be increased when Baricitinib is combined with Avacincaptad pegol.
Avacopan
The risk or severity of adverse effects can be increased when Baricitinib is combined with Avacopan.
Azacitidine
The risk or severity of adverse effects can be increased when Azacitidine is combined with Baricitinib.
Azathioprine
The risk or severity of adverse effects can be increased when Azathioprine is combined with Baricitinib.
Bacillus calmette-guerin substrain tice live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Baricitinib.
Basiliximab
The risk or severity of adverse effects can be increased when Basiliximab is combined with Baricitinib.
Beclomethasone dipropionate
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Baricitinib.
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Baricitinib.
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Baricitinib.
Belinostat
The risk or severity of adverse effects can be increased when Belinostat is combined with Baricitinib.
Belumosudil
The risk or severity of adverse effects can be increased when Baricitinib is combined with Belumosudil.
Bendamustine
The risk or severity of adverse effects can be increased when Bendamustine is combined with Baricitinib.
Betamethasone
The risk or severity of adverse effects can be increased when Betamethasone is combined with Baricitinib.
Bexarotene
The risk or severity of adverse effects can be increased when Bexarotene is combined with Baricitinib.
Bimekizumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Bimekizumab.
Bleomycin
The risk or severity of adverse effects can be increased when Bleomycin is combined with Baricitinib.
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Baricitinib.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Baricitinib.
Bosutinib
The risk or severity of adverse effects can be increased when Bosutinib is combined with Baricitinib.
Brentuximab vedotin
The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Baricitinib.
Brodalumab
The risk or severity of adverse effects can be increased when Brodalumab is combined with Baricitinib.
Budesonide
The risk or severity of adverse effects can be increased when Budesonide is combined with Baricitinib.
Busulfan
The risk or severity of adverse effects can be increased when Busulfan is combined with Baricitinib.
Cabazitaxel
The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Baricitinib.
Canakinumab
The risk or severity of adverse effects can be increased when Canakinumab is combined with Baricitinib.
Capecitabine
The risk or severity of adverse effects can be increased when Capecitabine is combined with Baricitinib.
Carbamazepine
The risk or severity of adverse effects can be increased when Carbamazepine is combined with Baricitinib.
Carboplatin
The risk or severity of adverse effects can be increased when Carboplatin is combined with Baricitinib.
Carfilzomib
The risk or severity of adverse effects can be increased when Carfilzomib is combined with Baricitinib.
Carmustine
The risk or severity of adverse effects can be increased when Carmustine is combined with Baricitinib.
Certolizumab pegol
The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Baricitinib.
Chikungunya vaccine (live, attenuated)
The risk or severity of infection can be increased when Chikungunya vaccine (live, attenuated) is combined with Baricitinib.
Chlorambucil
The risk or severity of adverse effects can be increased when Chlorambucil is combined with Baricitinib.
Chloramphenicol
The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Baricitinib.
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Baricitinib.
Cisplatin
The risk or severity of adverse effects can be increased when Cisplatin is combined with Baricitinib.
Clarithromycin
The metabolism of Baricitinib can be decreased when combined with Clarithromycin.
Clobetasol propionate
The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Baricitinib.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Baricitinib.
Conivaptan
The metabolism of Baricitinib can be decreased when combined with Conivaptan.
Corticotropin
The risk or severity of adverse effects can be increased when Corticotropin is combined with Baricitinib.
Cortisone acetate
The risk or severity of adverse effects can be increased when Cortisone acetate is combined with Baricitinib.
Crovalimab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Crovalimab.
Curcumin
The metabolism of Baricitinib can be decreased when combined with Curcumin.
Cyclophosphamide
The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Baricitinib.
Cyclosporine
Baricitinib may increase the immunosuppressive activities of Cyclosporine.
Cytarabine
The risk or severity of adverse effects can be increased when Cytarabine is combined with Baricitinib.
Dacarbazine
The risk or severity of adverse effects can be increased when Dacarbazine is combined with Baricitinib.
Dactinomycin
The risk or severity of adverse effects can be increased when Dactinomycin is combined with Baricitinib.
Danazol
The metabolism of Baricitinib can be decreased when combined with Danazol.
Danicopan
The risk or severity of adverse effects can be increased when Baricitinib is combined with Danicopan.
Darunavir
The metabolism of Baricitinib can be decreased when combined with Darunavir.
Dasatinib
The risk or severity of adverse effects can be increased when Dasatinib is combined with Baricitinib.
Daunorubicin
The risk or severity of adverse effects can be increased when Daunorubicin is combined with Baricitinib.
Decitabine
The risk or severity of adverse effects can be increased when Decitabine is combined with Baricitinib.
Deflazacort
The risk or severity of adverse effects can be increased when Baricitinib is combined with Deflazacort.
Desoximetasone
The risk or severity of adverse effects can be increased when Desoximetasone is combined with Baricitinib.
Deucravacitinib
The risk or severity of adverse effects can be increased when Baricitinib is combined with Deucravacitinib.
Dexamethasone
The risk or severity of adverse effects can be increased when Dexamethasone is combined with Baricitinib.
Dexrazoxane
The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Baricitinib.
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Baricitinib.
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Baricitinib.
Diroximel fumarate
The risk or severity of adverse effects can be increased when Baricitinib is combined with Diroximel fumarate.
Docetaxel
The risk or severity of adverse effects can be increased when Docetaxel is combined with Baricitinib.
Doxorubicin
The risk or severity of adverse effects can be increased when Doxorubicin is combined with Baricitinib.
Eculizumab
The risk or severity of adverse effects can be increased when Eculizumab is combined with Baricitinib.
Efavirenz
The metabolism of Baricitinib can be decreased when combined with Efavirenz.
Efgartigimod alfa
The risk or severity of adverse effects can be increased when Baricitinib is combined with Efgartigimod alfa.
Elvitegravir
The metabolism of Baricitinib can be decreased when combined with Elvitegravir.
Emapalumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Emapalumab.
Epirubicin
The risk or severity of adverse effects can be increased when Epirubicin is combined with Baricitinib.
Ergotamine
The metabolism of Baricitinib can be decreased when combined with Ergotamine.
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Baricitinib.
Etanercept
The risk or severity of adverse effects can be increased when Etanercept is combined with Baricitinib.
Etoposide
The risk or severity of adverse effects can be increased when Etoposide is combined with Baricitinib.
Everolimus
The risk or severity of adverse effects can be increased when Everolimus is combined with Baricitinib.
Floxuridine
The risk or severity of adverse effects can be increased when Floxuridine is combined with Baricitinib.
Flucytosine
The risk or severity of adverse effects can be increased when Flucytosine is combined with Baricitinib.
Fludarabine
The risk or severity of adverse effects can be increased when Fludarabine is combined with Baricitinib.
Fludrocortisone
The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Baricitinib.
Flunisolide
The risk or severity of adverse effects can be increased when Flunisolide is combined with Baricitinib.
Fluocinolone acetonide
The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Baricitinib.
Fluocinonide
The risk or severity of adverse effects can be increased when Fluocinonide is combined with Baricitinib.
Fluorometholone
The risk or severity of adverse effects can be increased when Fluorometholone is combined with Baricitinib.
Fluorouracil
The risk or severity of adverse effects can be increased when Fluorouracil is combined with Baricitinib.
Fluticasone furoate
The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with Baricitinib.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Baricitinib.
Fosphenytoin
The metabolism of Baricitinib can be increased when combined with Fosphenytoin.
Gemcitabine
The risk or severity of adverse effects can be increased when Gemcitabine is combined with Baricitinib.
Gemtuzumab ozogamicin
The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Baricitinib.
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Baricitinib.
Golimumab
The risk or severity of adverse effects can be increased when Golimumab is combined with Baricitinib.
Guselkumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Guselkumab.
Human adenovirus e serotype 4 strain cl-68578 antigen
The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Baricitinib.
Hydrocortisone acetate
The risk or severity of adverse effects can be increased when Baricitinib is combined with Hydrocortisone acetate.
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Baricitinib is combined with Hydrocortisone butyrate.
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Baricitinib is combined with Hydrocortisone succinate.
Hydroxychloroquine
The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Baricitinib.
Hydroxyurea
The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Baricitinib.
Ibritumomab tiuxetan
The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Baricitinib.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Baricitinib.
Idarubicin
The risk or severity of adverse effects can be increased when Idarubicin is combined with Baricitinib.
Idelalisib
The risk or severity of adverse effects can be increased when Idelalisib is combined with Baricitinib.
Ifosfamide
The risk or severity of adverse effects can be increased when Ifosfamide is combined with Baricitinib.
Imatinib
The risk or severity of adverse effects can be increased when Imatinib is combined with Baricitinib.
Indinavir
The metabolism of Baricitinib can be decreased when combined with Indinavir.
Infliximab
The risk or severity of adverse effects can be increased when Infliximab is combined with Baricitinib.
Interferon alfa-2b
The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Baricitinib.
Interferon alfa-n3
The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Baricitinib.
Interferon beta-1b
The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Baricitinib.
Interferon gamma-1b
The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Baricitinib.
Iptacopan
The risk or severity of adverse effects can be increased when Baricitinib is combined with Iptacopan.
Irinotecan
The risk or severity of adverse effects can be increased when Irinotecan is combined with Baricitinib.
Itraconazole
The metabolism of Baricitinib can be decreased when combined with Itraconazole.
Ixabepilone
The risk or severity of adverse effects can be increased when Ixabepilone is combined with Baricitinib.
Ixekizumab
The risk or severity of adverse effects can be increased when Ixekizumab is combined with Baricitinib.
Ketoconazole
The metabolism of Baricitinib can be decreased when combined with Ketoconazole.
Lenalidomide
The risk or severity of adverse effects can be increased when Lenalidomide is combined with Baricitinib.
Levoketoconazole
The metabolism of Baricitinib can be decreased when combined with Levoketoconazole.
Lomustine
The risk or severity of adverse effects can be increased when Lomustine is combined with Baricitinib.
Lonafarnib
The metabolism of Baricitinib can be decreased when combined with Lonafarnib.
Lumacaftor
The metabolism of Baricitinib can be increased when combined with Lumacaftor.
Mechlorethamine
The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Baricitinib.
Melphalan
The risk or severity of adverse effects can be increased when Melphalan is combined with Baricitinib.
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Baricitinib.
Methimazole
The metabolism of Baricitinib can be decreased when combined with Methimazole.
Methylprednisolone
The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Baricitinib.
Midostaurin
The metabolism of Baricitinib can be decreased when combined with Midostaurin.
Mirikizumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Mirikizumab.
Mitomycin
The risk or severity of adverse effects can be increased when Mitomycin is combined with Baricitinib.
Mitotane
The metabolism of Baricitinib can be increased when combined with Mitotane.
Mitoxantrone
The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Baricitinib.
Mometasone furoate
The risk or severity of adverse effects can be increased when Baricitinib is combined with Mometasone furoate.
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Baricitinib is combined with Monomethyl fumarate.
Mosunetuzumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Mosunetuzumab.
Mycophenolate mofetil
The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Baricitinib.
Mycophenolic acid
The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Baricitinib.
Natalizumab
The risk or severity of immunosuppression can be increased when Baricitinib is combined with Natalizumab.
Nefazodone
The metabolism of Baricitinib can be decreased when combined with Nefazodone.
Nelarabine
The risk or severity of adverse effects can be increased when Nelarabine is combined with Baricitinib.
Nelfinavir
The metabolism of Baricitinib can be decreased when combined with Nelfinavir.
Nilotinib
The metabolism of Baricitinib can be decreased when combined with Nilotinib.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Baricitinib.
Ocrelizumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Ocrelizumab.
Ofatumumab
The risk or severity of adverse effects can be increased when Ofatumumab is combined with Baricitinib.
Olaparib
The risk or severity of adverse effects can be increased when Olaparib is combined with Baricitinib.
Oxaliplatin
The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Baricitinib.
Ozanimod
The risk or severity of adverse effects can be increased when Baricitinib is combined with Ozanimod.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Baricitinib.
Palbociclib
The risk or severity of adverse effects can be increased when Palbociclib is combined with Baricitinib.
Panobinostat
The risk or severity of adverse effects can be increased when Panobinostat is combined with Baricitinib.
Pazopanib
The risk or severity of adverse effects can be increased when Pazopanib is combined with Baricitinib.
Pegaspargase
The risk or severity of adverse effects can be increased when Pegaspargase is combined with Baricitinib.
Pegcetacoplan
The risk or severity of adverse effects can be increased when Baricitinib is combined with Pegcetacoplan.
Peginterferon alfa-2a
The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Baricitinib.
Peginterferon alfa-2b
The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Baricitinib.
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Baricitinib.
Pemetrexed
The risk or severity of adverse effects can be increased when Pemetrexed is combined with Baricitinib.
Penicillamine
The risk or severity of adverse effects can be increased when Penicillamine is combined with Baricitinib.
Pentobarbital
The metabolism of Baricitinib can be increased when combined with Pentobarbital.
Pentostatin
The risk or severity of adverse effects can be increased when Pentostatin is combined with Baricitinib.
Phenobarbital
The metabolism of Baricitinib can be increased when combined with Phenobarbital.
Phenylalanine
The risk or severity of adverse effects can be increased when Phenylalanine is combined with Baricitinib.
Phenytoin
The metabolism of Baricitinib can be increased when combined with Phenytoin.
Pimecrolimus
The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Baricitinib.
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Baricitinib.
Pirtobrutinib
The risk or severity of adverse effects can be increased when Baricitinib is combined with Pirtobrutinib.
Pomalidomide
The risk or severity of adverse effects can be increased when Pomalidomide is combined with Baricitinib.
Ponatinib
The risk or severity of adverse effects can be increased when Ponatinib is combined with Baricitinib.
Ponesimod
The risk or severity of adverse effects can be increased when Baricitinib is combined with Ponesimod.
Posaconazole
The metabolism of Baricitinib can be decreased when combined with Posaconazole.
Pozelimab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Pozelimab.
Pralatrexate
The risk or severity of adverse effects can be increased when Pralatrexate is combined with Baricitinib.
Prednisolone
The risk or severity of adverse effects can be increased when Prednisolone is combined with Baricitinib.
Prednisone
The risk or severity of adverse effects can be increased when Prednisone is combined with Baricitinib.
Primidone
The metabolism of Baricitinib can be increased when combined with Primidone.
Procainamide
The excretion of Procainamide can be decreased when combined with Baricitinib.
Procarbazine
The risk or severity of adverse effects can be increased when Procarbazine is combined with Baricitinib.
Propylthiouracil
The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Baricitinib.
Ravulizumab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Baricitinib.
Ribociclib
The metabolism of Baricitinib can be decreased when combined with Ribociclib.
Rifampin
The metabolism of Baricitinib can be increased when combined with Rifampin.
Rifapentine
The metabolism of Baricitinib can be increased when combined with Rifapentine.
Rilonacept
The risk or severity of adverse effects can be increased when Rilonacept is combined with Baricitinib.
Risankizumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Risankizumab.
Rituximab
The risk or severity of adverse effects can be increased when Rituximab is combined with Baricitinib.
Ropeginterferon alfa-2b
The risk or severity of adverse effects can be increased when Baricitinib is combined with Ropeginterferon alfa-2b.
Rozanolixizumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Rozanolixizumab.
Rubella virus vaccine
The risk or severity of infection can be increased when Rubella virus vaccine is combined with Baricitinib.
Ruxolitinib
The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Baricitinib.
Saquinavir
The metabolism of Baricitinib can be decreased when combined with Saquinavir.
Sarilumab
The risk or severity of adverse effects can be increased when Sarilumab is combined with Baricitinib.
Secukinumab
The risk or severity of adverse effects can be increased when Secukinumab is combined with Baricitinib.
Siltuximab
The risk or severity of adverse effects can be increased when Siltuximab is combined with Baricitinib.
Siponimod
The risk or severity of adverse effects can be increased when Baricitinib is combined with Siponimod.
Sirolimus
The risk or severity of adverse effects can be increased when Sirolimus is combined with Baricitinib.
Smallpox (Vaccinia) Vaccine, Live
The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Baricitinib.
Sorafenib
The risk or severity of adverse effects can be increased when Sorafenib is combined with Baricitinib.
Spesolimab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Spesolimab.
Streptozocin
The risk or severity of adverse effects can be increased when Streptozocin is combined with Baricitinib.
Sulfasalazine
The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Baricitinib.
Sunitinib
The risk or severity of adverse effects can be increased when Sunitinib is combined with Baricitinib.
Sutimlimab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Sutimlimab.
Telithromycin
The metabolism of Baricitinib can be decreased when combined with Telithromycin.
Temozolomide
The risk or severity of adverse effects can be increased when Temozolomide is combined with Baricitinib.
Temsirolimus
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Baricitinib.
Teniposide
The risk or severity of adverse effects can be increased when Teniposide is combined with Baricitinib.
Teprotumumab
The risk or severity of adverse effects can be increased when Teprotumumab is combined with Baricitinib.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Baricitinib.
Thiotepa
The risk or severity of adverse effects can be increased when Thiotepa is combined with Baricitinib.
Tioguanine
The risk or severity of adverse effects can be increased when Tioguanine is combined with Baricitinib.
Tipranavir
The metabolism of Baricitinib can be decreased when combined with Tipranavir.
Tixocortol
The risk or severity of adverse effects can be increased when Tixocortol is combined with Baricitinib.
Tocilizumab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Baricitinib.
Topotecan
The risk or severity of adverse effects can be increased when Topotecan is combined with Baricitinib.
Trabectedin
The risk or severity of adverse effects can be increased when Trabectedin is combined with Baricitinib.
Trastuzumab emtansine
The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Baricitinib.
Triamcinolone
The risk or severity of adverse effects can be increased when Triamcinolone is combined with Baricitinib.
Trifluridine
The risk or severity of adverse effects can be increased when Trifluridine is combined with Baricitinib.
Typhoid Vaccine Live
The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Baricitinib.
Upadacitinib
The risk or severity of adverse effects can be increased when Baricitinib is combined with Upadacitinib.
Varicella zoster vaccine (live/attenuated)
The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Baricitinib.
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Baricitinib.
Vibrio cholerae CVD 103-HgR strain live antigen
The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Baricitinib.
Vilanterol
The risk or severity of adverse effects can be increased when Vilanterol is combined with Baricitinib.
Vinblastine
The risk or severity of adverse effects can be increased when Vinblastine is combined with Baricitinib.
Vincristine
The risk or severity of adverse effects can be increased when Vincristine is combined with Baricitinib.
Vinorelbine
The risk or severity of adverse effects can be increased when Vinorelbine is combined with Baricitinib.
Voclosporin
The risk or severity of adverse effects can be increased when Voclosporin is combined with Baricitinib.
Voriconazole
The metabolism of Baricitinib can be decreased when combined with Voriconazole.
Vorinostat
The risk or severity of adverse effects can be increased when Vorinostat is combined with Baricitinib.
Yellow fever vaccine
The risk or severity of infection can be increased when Yellow fever vaccine is combined with Baricitinib.
Zilucoplan
The risk or severity of adverse effects can be increased when Baricitinib is combined with Zilucoplan.
Abemaciclib
The excretion of Baricitinib can be decreased when combined with Abemaciclib.
Acetylsalicylic acid
The serum concentration of Baricitinib can be increased when it is combined with Acetylsalicylic acid.
Acyclovir
The serum concentration of Baricitinib can be increased when it is combined with Acyclovir.
Amikacin
Baricitinib may decrease the excretion rate of Amikacin which could result in a higher serum level.
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Baricitinib.
Apalutamide
The serum concentration of Baricitinib can be increased when it is combined with Apalutamide.
Aprepitant
The metabolism of Baricitinib can be decreased when combined with Aprepitant.
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Baricitinib.
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Baricitinib.
Benzoic acid
The serum concentration of Baricitinib can be increased when it is combined with Benzoic acid.
Benzylpenicillin
The serum concentration of Baricitinib can be increased when it is combined with Benzylpenicillin.
Berotralstat
The metabolism of Baricitinib can be decreased when combined with Berotralstat.
Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Baricitinib.
Brigatinib
The excretion of Baricitinib can be decreased when combined with Brigatinib.
Bumetanide
The serum concentration of Baricitinib can be increased when it is combined with Bumetanide.
Cabotegravir
The serum concentration of Baricitinib can be increased when it is combined with Cabotegravir.
Capivasertib
The serum concentration of Baricitinib can be increased when it is combined with Capivasertib.
Capmatinib
The excretion of Baricitinib can be decreased when combined with Capmatinib.
Capreomycin
Baricitinib may decrease the excretion rate of Capreomycin which could result in a higher serum level.
Cefaclor
The serum concentration of Baricitinib can be increased when it is combined with Cefaclor.
Cefadroxil
The serum concentration of Baricitinib can be increased when it is combined with Cefadroxil.
Cefazolin
The serum concentration of Baricitinib can be increased when it is combined with Cefazolin.
Cefotaxime
The serum concentration of Baricitinib can be increased when it is combined with Cefotaxime.
Ceftibuten
The serum concentration of Baricitinib can be increased when it is combined with Ceftibuten.
Ceftizoxime
The serum concentration of Baricitinib can be increased when it is combined with Ceftizoxime.
Ceftriaxone
The serum concentration of Baricitinib can be increased when it is combined with Ceftriaxone.
Cenobamate
The serum concentration of Baricitinib can be decreased when it is combined with Cenobamate.
Cephalexin
The serum concentration of Baricitinib can be increased when it is combined with Cephalexin.
Cholic Acid
The serum concentration of Baricitinib can be increased when it is combined with Cholic Acid.
Cilastatin
The serum concentration of Baricitinib can be increased when it is combined with Cilastatin.
Cimetidine
The serum concentration of Baricitinib can be increased when it is combined with Cimetidine.
Ciprofloxacin
The metabolism of Baricitinib can be decreased when combined with Ciprofloxacin.
Clostridium tetani toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Baricitinib.
Clozapine
The metabolism of Baricitinib can be decreased when combined with Clozapine.
Colistin
Baricitinib may decrease the excretion rate of Colistin which could result in a higher serum level.
Conjugated estrogens
The serum concentration of Baricitinib can be increased when it is combined with Conjugated estrogens.
Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Baricitinib.
Dabrafenib
The serum concentration of Baricitinib can be increased when it is combined with Dabrafenib.
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Baricitinib.
Desvenlafaxine
The metabolism of Baricitinib can be decreased when combined with Desvenlafaxine.
Diclofenac
The serum concentration of Baricitinib can be increased when it is combined with Diclofenac.
Digoxin
Baricitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.
Diltiazem
The metabolism of Baricitinib can be decreased when combined with Diltiazem.
Dinoprostone
The serum concentration of Baricitinib can be increased when it is combined with Dinoprostone.
Dolutegravir
The serum concentration of Baricitinib can be increased when it is combined with Dolutegravir.
Dronedarone
The serum concentration of Baricitinib can be increased when it is combined with Dronedarone.
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Baricitinib.
Elasomeran
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Baricitinib.
Enalapril
The serum concentration of Baricitinib can be increased when it is combined with Enalapril.
Enasidenib
The serum concentration of Baricitinib can be increased when it is combined with Enasidenib.
Encorafenib
The serum concentration of Baricitinib can be increased when it is combined with Encorafenib.
Enzalutamide
The serum concentration of Baricitinib can be decreased when it is combined with Enzalutamide.
Epcoritamab
The serum concentration of Baricitinib can be increased when it is combined with Epcoritamab.
Erythromycin
The serum concentration of Baricitinib can be increased when it is combined with Erythromycin.
Esomeprazole
The serum concentration of Baricitinib can be increased when it is combined with Esomeprazole.
Estrone sulfate
The excretion of Baricitinib can be decreased when combined with Estrone sulfate.
Etrasimod
The risk or severity of immunosuppression can be increased when Baricitinib is combined with Etrasimod.
Famotidine
The serum concentration of Baricitinib can be increased when it is combined with Famotidine.
Fedratinib
The serum concentration of Baricitinib can be increased when it is combined with Fedratinib.
Fexinidazole
The serum concentration of Baricitinib can be increased when it is combined with Fexinidazole.
Fingolimod
Baricitinib may increase the immunosuppressive activities of Fingolimod.
Fluconazole
The metabolism of Baricitinib can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Baricitinib can be decreased when combined with Fluvoxamine.
Fosnetupitant
The metabolism of Baricitinib can be decreased when combined with Fosnetupitant.
Furosemide
The serum concentration of Baricitinib can be increased when it is combined with Furosemide.
Fusidic acid
The metabolism of Baricitinib can be decreased when combined with Fusidic acid.
Ganciclovir
The serum concentration of Baricitinib can be increased when it is combined with Ganciclovir.
Gemfibrozil
The serum concentration of Baricitinib can be increased when it is combined with Gemfibrozil.
Gentamicin
Baricitinib may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Glasdegib
The excretion of Baricitinib can be decreased when combined with Glasdegib.
Glofitamab
The serum concentration of Baricitinib can be increased when it is combined with Glofitamab.
Guanidine
The serum concentration of Baricitinib can be increased when it is combined with Guanidine.
Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Baricitinib.
Haloperidol
The serum concentration of Haloperidol can be increased when it is combined with Baricitinib.
Hepatitis A Vaccine
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Baricitinib.
Hepatitis B Vaccine (Recombinant)
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Baricitinib.
Ibuprofen
The serum concentration of Baricitinib can be increased when it is combined with Ibuprofen.
Indomethacin
The serum concentration of Baricitinib can be increased when it is combined with Indomethacin.
Isavuconazonium
The metabolism of Baricitinib can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Baricitinib can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Baricitinib can be decreased when combined with Isradipine.
Istradefylline
The excretion of Baricitinib can be decreased when combined with Istradefylline.
Ivacaftor
The serum concentration of Baricitinib can be increased when it is combined with Ivacaftor.
Ivosidenib
The metabolism of Baricitinib can be increased when combined with Ivosidenib.
Janssen COVID-19 Vaccine
The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Baricitinib.
Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Baricitinib.
Ketoprofen
The serum concentration of Baricitinib can be increased when it is combined with Ketoprofen.
Lansoprazole
The serum concentration of Baricitinib can be increased when it is combined with Lansoprazole.
Latanoprost
The serum concentration of Baricitinib can be increased when it is combined with Latanoprost.
Leflunomide
The risk or severity of adverse effects can be increased when Baricitinib is combined with Leflunomide.
Lenvatinib
The serum concentration of Baricitinib can be increased when it is combined with Lenvatinib.
Leucovorin
The serum concentration of Baricitinib can be increased when it is combined with Leucovorin.
Linagliptin
The metabolism of Baricitinib can be decreased when combined with Linagliptin.
Linezolid
The serum concentration of Baricitinib can be increased when it is combined with Linezolid.
Liothyronine
The serum concentration of Baricitinib can be increased when it is combined with Liothyronine.
Lithium carbonate
Baricitinib may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
Lopinavir
The serum concentration of Baricitinib can be increased when it is combined with Lopinavir.
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Baricitinib.
Mavacamten
The serum concentration of Baricitinib can be decreased when it is combined with Mavacamten.
Measles virus vaccine live attenuated
The therapeutic efficacy of Measles virus vaccine live attenuated can be decreased when used in combination with Baricitinib.
Melatonin
The serum concentration of Baricitinib can be increased when it is combined with Melatonin.
Mercaptopurine
The serum concentration of Baricitinib can be increased when it is combined with Mercaptopurine.
Metformin
The excretion of Baricitinib can be decreased when combined with Metformin.
Methotrexate
The serum concentration of Baricitinib can be increased when it is combined with Methotrexate.
Methylene blue
The excretion of Baricitinib can be decreased when combined with Methylene blue.
Methyltestosterone
The excretion of Baricitinib can be increased when combined with Methyltestosterone.
Miconazole
The metabolism of Baricitinib can be decreased when combined with Miconazole.
Milnacipran
The metabolism of Baricitinib can be decreased when combined with Milnacipran.
Minocycline
The serum concentration of Baricitinib can be increased when it is combined with Minocycline.
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Baricitinib.
mRNA-1345
The therapeutic efficacy of mRNA-1345 can be decreased when used in combination with Baricitinib.
Mumps virus strain B level jeryl lynn live antigen
The therapeutic efficacy of Mumps virus strain B level jeryl lynn live antigen can be decreased when used in combination with Baricitinib.
Nadolol
The excretion of Baricitinib can be decreased when combined with Nadolol.
Neomycin
Baricitinib may decrease the excretion rate of Neomycin which could result in a higher serum level.
Netupitant
The metabolism of Baricitinib can be decreased when combined with Netupitant.
Nicardipine
The metabolism of Baricitinib can be decreased when combined with Nicardipine.
Nuvaxovid
The therapeutic efficacy of Nuvaxovid can be decreased when used in combination with Baricitinib.
Oxytetracycline
The serum concentration of Baricitinib can be increased when it is combined with Oxytetracycline.
Pantoprazole
The serum concentration of Baricitinib can be increased when it is combined with Pantoprazole.
Pexidartinib
The excretion of Baricitinib can be decreased when combined with Pexidartinib.
Piroxicam
The serum concentration of Baricitinib can be increased when it is combined with Piroxicam.
Pitolisant
The serum concentration of Baricitinib can be decreased when it is combined with Pitolisant.
Plazomicin
Baricitinib may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Pralsetinib
The excretion of Baricitinib can be decreased when combined with Pralsetinib.
Pravastatin
The serum concentration of Baricitinib can be increased when it is combined with Pravastatin.
Pretomanid
The serum concentration of Baricitinib can be increased when it is combined with Pretomanid.
Primaquine
The metabolism of Baricitinib can be decreased when combined with Primaquine.
Probenecid
The serum concentration of Baricitinib can be increased when it is combined with Probenecid.
Pyrimethamine
The excretion of Baricitinib can be decreased when combined with Pyrimethamine.
Quinidine
The serum concentration of Baricitinib can be increased when it is combined with Quinidine.
Rabies immune globulin, human
The therapeutic efficacy of Rabies immune globulin, human can be decreased when used in combination with Baricitinib.
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Baricitinib.
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Baricitinib.
Ranolazine
The excretion of Baricitinib can be decreased when combined with Ranolazine.
Relebactam
The excretion of Relebactam can be decreased when combined with Baricitinib.
Repotrectinib
The excretion of Baricitinib can be decreased when combined with Repotrectinib.
Respiratory syncytial virus vaccine, adjuvanted
The therapeutic efficacy of GSK-3844766A can be decreased when used in combination with Baricitinib.
Risdiplam
The serum concentration of Baricitinib can be increased when it is combined with Risdiplam.
Ritlecitinib
The serum concentration of Baricitinib can be increased when it is combined with Ritlecitinib.
Ritonavir
The serum concentration of Baricitinib can be increased when it is combined with Ritonavir.
Rosuvastatin
The serum concentration of Baricitinib can be increased when it is combined with Rosuvastatin.
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Baricitinib.
Salicylic acid
The serum concentration of Baricitinib can be increased when it is combined with Salicylic acid.
Satralizumab
The serum concentration of Baricitinib can be decreased when it is combined with Satralizumab.
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Baricitinib.
Sotorasib
The serum concentration of Baricitinib can be decreased when it is combined with Sotorasib.
Stiripentol
The metabolism of Baricitinib can be decreased when combined with Stiripentol.
Streptomycin
Baricitinib may decrease the excretion rate of Streptomycin which could result in a higher serum level.
Sulfamethoxazole
The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Baricitinib.
Tacrolimus
Tacrolimus may increase the immunosuppressive activities of Baricitinib.
Tafamidis
The serum concentration of Baricitinib can be increased when it is combined with Tafamidis.
Tafenoquine
The excretion of Baricitinib can be decreased when combined with Tafenoquine.
Taletrectinib
The excretion of Baricitinib can be decreased when combined with Taletrectinib.
Tazemetostat
The excretion of Baricitinib can be decreased when combined with Tazemetostat.
Tazobactam
The serum concentration of Baricitinib can be increased when it is combined with Tazobactam.
Telotristat ethyl
The serum concentration of Baricitinib can be decreased when it is combined with Telotristat ethyl.
Tenofovir alafenamide
The serum concentration of Tenofovir alafenamide can be increased when it is combined with Baricitinib.
Teriflunomide
The serum concentration of Baricitinib can be increased when it is combined with Teriflunomide.
Testosterone
The excretion of Baricitinib can be increased when combined with Testosterone.
Testosterone cypionate
The excretion of Baricitinib can be increased when combined with Testosterone cypionate.
Testosterone enanthate
The excretion of Baricitinib can be increased when combined with Testosterone enanthate.
Tetracycline
The serum concentration of Baricitinib can be increased when it is combined with Tetracycline.
Tick-borne encephalitis vaccine (whole virus, inactivated)
The therapeutic efficacy of Tick-borne encephalitis vaccine (whole virus, inactivated) can be decreased when used in combination with Baricitinib.
Tobramycin
Baricitinib may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Tofacitinib
Baricitinib may increase the immunosuppressive activities of Tofacitinib.
Trastuzumab
The risk or severity of neutropenia can be increased when Trastuzumab is combined with Baricitinib.
Trilaciclib
The excretion of Baricitinib can be decreased when combined with Trilaciclib.
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Baricitinib.
Typhoid vaccine
The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Baricitinib.
Typhoid Vi polysaccharide vaccine
The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Baricitinib.
Ublituximab
The risk or severity of infection can be increased when Ublituximab is combined with Baricitinib.
Vadadustat
The serum concentration of Baricitinib can be increased when it is combined with Vadadustat.
Valproic acid
The serum concentration of Baricitinib can be increased when it is combined with Valproic acid.
Vancomycin
Baricitinib may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Varicella zoster vaccine (recombinant)
The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Baricitinib.
Venetoclax
The metabolism of Baricitinib can be decreased when combined with Venetoclax.
Verapamil
The metabolism of Baricitinib can be decreased when combined with Verapamil.
Warfarin
Baricitinib may decrease the excretion rate of Warfarin which could result in a higher serum level.
Zidovudine
The serum concentration of Baricitinib can be increased when it is combined with Zidovudine.
Ziprasidone
The metabolism of Baricitinib can be decreased when combined with Ziprasidone.
Abacavir
Abacavir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Aceclofenac
Aceclofenac may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Acetaminophen
Acetaminophen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Acetazolamide
Acetazolamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Aclidinium
Aclidinium may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Acrivastine
Acrivastine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Adefovir dipivoxil
Adefovir dipivoxil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Albuterol
Salbutamol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Albutrepenonacog alfa
Baricitinib may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
Allogeneic processed thymus tissue
The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Baricitinib.
Allopurinol
Allopurinol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Almasilate
Baricitinib may decrease the excretion rate of Almasilate which could result in a higher serum level.
Almotriptan
Almotriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Alogliptin
Alogliptin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Alprazolam
Alprazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Amantadine
Amantadine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Amiloride
Amiloride may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Amitriptyline
Amitriptyline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ammonium chloride
Ammonium chloride may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Amoxicillin
Amoxicillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Amphetamine
Amphetamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Amphotericin B
Amphotericin B may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ampicillin
Ampicillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Baricitinib.
Antipyrine
Antipyrine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Antithrombin III human
Antithrombin III human may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Arformoterol
Arformoterol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Atomoxetine
Atomoxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Auranofin
Auranofin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Azelaic acid
Azelaic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Aztreonam
Aztreonam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Bacitracin
Bacitracin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Baclofen
Baclofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Balsalazide
Balsalazide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Bendroflumethiazide
Bendroflumethiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Benzatropine
Benzatropine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Benznidazole
Baricitinib may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Bepotastine
Bepotastine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Bicisate
Bicisate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Bismuth subgallate
Baricitinib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
Bisoprolol
Bisoprolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Brivaracetam
Brivaracetam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Bromotheophylline
Bromotheophylline may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Bupropion
Bupropion may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Buspirone
Buspirone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Canagliflozin
Canagliflozin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Carbidopa
Carbidopa may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefdinir
Cefdinir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefditoren
Cefditoren may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefepime
Cefepime may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefotetan
Cefotetan may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefoxitin
Cefoxitin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefpodoxime
Cefpodoxime may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefprozil
Cefprozil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ceftaroline fosamil
Ceftaroline fosamil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ceftazidime
Ceftazidime may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ceftolozane
Ceftolozane may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cefuroxime
Cefuroxime may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Celecoxib
Celecoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cetirizine
Cetirizine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cevimeline
Cevimeline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Chloroquine
Chloroquine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Chlorothiazide
Chlorothiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Chlorpromazine
Chlorpromazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Chlorthalidone
Chlorthalidone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Chlorzoxazone
Chlorzoxazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Choline salicylate
Baricitinib may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
Chondroitin sulfate
Chondroitin sulfate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Chromic chloride
Chromic chloride may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Chromium
Chromium may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Chromium nicotinate
Baricitinib may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
Cidofovir
Cidofovir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cilostazol
Cilostazol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cladribine
Baricitinib may increase the immunosuppressive activities of Cladribine.
Clevidipine
Clevidipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Clobazam
Clobazam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Clomipramine
Clomipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Clonazepam
Clonazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Clorazepic acid
Clorazepic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Clove oil
Clove oil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Colchicine
Colchicine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Colistimethate
Colistimethate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Cyanocobalamin
Cyanocobalamin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dabigatran etexilate
Dabigatran etexilate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dalfampridine
Dalfampridine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Daptomycin
Daptomycin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Deferiprone
Deferiprone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Delafloxacin
Baricitinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Desipramine
Desipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Desmopressin
Desmopressin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Deutetrabenazine
Baricitinib may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Dexmedetomidine
Dexmedetomidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dexpanthenol
Dexpanthenol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dextran
Dextran may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Diatrizoate
Diatrizoate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Diazepam
Diazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Diclofenamide
Diclofenamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Dicyclomine
Dicyclomine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Didanosine
Didanosine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dienogest
Dienogest may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Diflunisal
Diflunisal may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dimercaprol
Dimercaprol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dimethyl sulfoxide
Dimethyl sulfoxide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Disopyramide
Disopyramide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
DL-Methylephedrine
DL-Methylephedrine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dobutamine
Dobutamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Dopamine
Dopamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Doxepin
Doxepin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Doxycycline
Doxycycline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Drospirenone
Drospirenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Droxidopa
Droxidopa may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Duloxetine
Duloxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Edoxaban
Edoxaban may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Edrophonium
Edrophonium may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Enalaprilat
Enalaprilat may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Eplerenone
Eplerenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Epoprostenol
Epoprostenol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ertapenem
Ertapenem may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Estazolam
Estazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Estradiol
Estradiol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Estradiol acetate
Baricitinib may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
Estradiol cypionate
Baricitinib may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
Estradiol valerate
Baricitinib may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
Eszopiclone
Eszopiclone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Etacrynic acid
Etacrynic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ethambutol
Ethambutol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ethenzamide
Ethenzamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Etodolac
Etodolac may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Etomidate
Etomidate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Etonogestrel
Etonogestrel may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Eucalyptus oil
Eucalyptus oil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Evening primrose oil
Evening primrose oil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fenofibrate
Fenofibrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fenofibric acid
Baricitinib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
Fenoldopam
Fenoldopam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fenoprofen
Fenoprofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fentanyl
Fentanyl may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fesoterodine
Fesoterodine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Finerenone
Finerenone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Flavoxate
Flavoxate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Florbetaben F-18
Florbetaben (18F) may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Florbetapir F-18
Florbetapir (18F) may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fludeoxyglucose (18F)
Fludeoxyglucose (18F) may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Flumazenil
Flumazenil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Flurazepam
Flurazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Flurbiprofen
Flurbiprofen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Flutamide
Flutamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Folic acid
Folic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fomepizole
Fomepizole may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fondaparinux
Fondaparinux may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Foscarnet
Foscarnet may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fosfomycin
Fosfomycin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Fosinopril
Fosinopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Gabapentin enacarbil
Gabapentin enacarbil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Gadobenic acid
Gadobenic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Gadodiamide
Gadodiamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Gadofosveset trisodium
Gadofosveset trisodium may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Gadoteric acid
Gadoteric acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Gadoteridol
Gadoteridol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Givosiran
Givosiran may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Glipizide
Glipizide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Glycerol phenylbutyrate
Glycerol phenylbutyrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Golodirsen
Baricitinib may decrease the excretion rate of Golodirsen which could result in a higher serum level.
Goserelin
Goserelin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Guanfacine
Guanfacine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Hydralazine
Hydralazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Hydrochlorothiazide
Hydrochlorothiazide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Hydroflumethiazide
Hydroflumethiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Hydromorphone
Hydromorphone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Hydroxocobalamin
Hydroxocobalamin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Hydroxyethyl Starch
Hydroxyethyl Starch may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ibutilide
Ibutilide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Icatibant
Icatibant may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Icosapent
Icosapent may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Idarucizumab
Idarucizumab may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Imipramine
Imipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Indapamide
Indapamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Indigotindisulfonic acid
Indigotindisulfonic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Inebilizumab
The risk or severity of infection can be increased when Baricitinib is combined with Inebilizumab.
Inositol
Baricitinib may decrease the excretion rate of Inositol which could result in a higher serum level.
Inotersen
Inotersen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Iobenguane sulfate I-123
Iobenguane sulfate I-123 may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Iodixanol
Iodixanol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ioflupane I-123
Ioflupane I-123 may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Iopromide
Iopromide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Iothalamic acid
Iothalamic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ioversol
Ioversol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ipecac
Baricitinib may decrease the excretion rate of Ipecac which could result in a higher serum level.
Ipilimumab
Ipilimumab may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Isosorbide
Isosorbide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide mononitrate
Isosorbide mononitrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Isosulfan blue
Isosulfan blue may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Isotretinoin
Isotretinoin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ixazomib
Ixazomib may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ketamine
Ketamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ketorolac
Ketorolac may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Labetalol
Labetalol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lamivudine
Lamivudine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lamotrigine
Lamotrigine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ledipasvir
Ledipasvir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Leuprolide
Leuprolide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Levocarnitine
Levocarnitine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Levocetirizine
Levocetirizine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Levofloxacin
Levofloxacin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Levomilnacipran
Levomilnacipran may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Levosalbutamol
Baricitinib may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
Lisinopril
Lisinopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lithium citrate
Lithium citrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lixisenatide
Lixisenatide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine
Lofexidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lorazepam
Lorazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lubiprostone
Lubiprostone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Macitentan
Macitentan may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Magnesium carbonate
Magnesium carbonate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Magnesium chloride
Magnesium chloride may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Magnesium hydroxide
Magnesium hydroxide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Magnesium salicylate
Magnesium salicylate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Magnesium trisilicate
Magnesium trisilicate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Mannitol
Mannitol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Maprotiline
Maprotiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Mecamylamine
Mecamylamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Meclofenamic acid
Meclofenamic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Medroxyprogesterone acetate
Medroxyprogesterone acetate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Mefenamic acid
Mefenamic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Megestrol acetate
Megestrol acetate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Meloxicam
Meloxicam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Memantine
Memantine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Meperidine
Meperidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Mepivacaine
Mepivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Meropenem
Meropenem may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Mesalazine
Mesalazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Metamfetamine
Metamfetamine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Metaxalone
Metaxalone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Methadone
Methadone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Methazolamide
Methazolamide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Methoxsalen
Methoxsalen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Methyldopa
Methyldopa may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Methylnaltrexone
Methylnaltrexone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Metoclopramide
Metoclopramide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Metolazone
Metolazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Metoprolol
Metoprolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Metreleptin
The metabolism of Baricitinib can be increased when combined with Metreleptin.
Metyrapone
Metyrapone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Midazolam
Midazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Migalastat
Migalastat may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Milrinone
Milrinone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Mirabegron
Mirabegron may decrease the excretion rate of Baricitinib which could result in a higher serum level.
N-acetyltyrosine
N-acetyltyrosine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nabumetone
Nabumetone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Naldemedine
Naldemedine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nalmefene
Nalmefene may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Naloxone
Naloxone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Naproxen
Naproxen may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nateglinide
Nateglinide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nedocromil
Nedocromil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nifedipine
Nifedipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nilutamide
Nilutamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nisoldipine
Nisoldipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nitric Oxide
Nitric Oxide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nitrofurantoin
Nitrofurantoin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Nitroprusside
Nitroprusside may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Octinoxate
Octinoxate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Olsalazine
Olsalazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Omaveloxolone
The serum concentration of Baricitinib can be decreased when it is combined with Omaveloxolone.
Opium
Opium may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Oseltamivir
Oseltamivir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Oxacillin
Oxacillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Oxaprozin
Oxaprozin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Oxazepam
Oxazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Oxybenzone
Oxybenzone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Oxyquinoline
Oxyquinoline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Paliperidone
Paliperidone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Palonosetron
Palonosetron may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pamidronic acid
Pamidronic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Parecoxib
Parecoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Paromomycin
Paromomycin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pentamidine
Pentamidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pentetic acid
Baricitinib may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
Pentoxifylline
Pentoxifylline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Perindopril
Perindopril may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Permethrin
Permethrin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Phenazopyridine
Phenazopyridine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Phenelzine
Phenelzine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Phosphoric acid
Phosphoric acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Phylloquinone
Phylloquinone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Picosulfuric acid
Picosulfuric acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pindolol
Pindolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Piperacillin
Piperacillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Plerixafor
Plerixafor may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Polythiazide
Polythiazide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Potassium
Potassium may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Potassium acetate
Baricitinib may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
Potassium bicarbonate
Potassium bicarbonate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Potassium cation
Potassium cation may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Potassium chloride
Potassium chloride may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Potassium citrate
Potassium citrate may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Potassium nitrate
Potassium nitrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Potassium sulfate
Baricitinib may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
Pralidoxime
Pralidoxime may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pramipexole
Pramipexole may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Prasugrel
Prasugrel may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pregabalin
Pregabalin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Procaine benzylpenicillin
Procaine benzylpenicillin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Promethazine
Promethazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Propantheline
Propantheline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Propranolol
Propranolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Propyphenazone
Propyphenazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Prucalopride
Prucalopride may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pyrantel
Pyrantel may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pyrazinamide
Pyrazinamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Pyridoxine
Pyridoxine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Quetiapine
Quetiapine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Rabeprazole
Rabeprazole may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ramelteon
Ramelteon may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ranitidine
Ranitidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Rasagiline
Rasagiline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Reserpine
Reserpine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Resorcinol
Resorcinol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ribavirin
Ribavirin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Rivaroxaban
Rivaroxaban may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Rizatriptan
Rizatriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Roflumilast
Roflumilast may increase the immunosuppressive activities of Baricitinib.
Ropivacaine
Ropivacaine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Rosiglitazone
Rosiglitazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sacubitril
Sacubitril may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Salicylamide
Salicylamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Salmon calcitonin
Salmon calcitonin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Salsalate
Salsalate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Saxagliptin
Saxagliptin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Secobarbital
Secobarbital may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Selenious acid
Selenious acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Selenium
Selenium may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sitagliptin
Sitagliptin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sodium acetate
Sodium acetate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sodium fluoride
Sodium fluoride may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sodium sulfate
Sodium sulfate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sofosbuvir
Sofosbuvir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Solriamfetol
Baricitinib may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Somatrogon
The metabolism of Baricitinib can be increased when combined with Somatrogon.
Sorbitol
Sorbitol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Spironolactone
Spironolactone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Sucralfate
Sucralfate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sulbactam
Sulbactam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sulfadiazine
Sulfadiazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sulindac
Sulindac may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Sumatriptan
Sumatriptan may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Synthetic Conjugated Estrogens, A
Synthetic Conjugated Estrogens, A may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Synthetic Conjugated Estrogens, B
Synthetic Conjugated Estrogens, B may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tadalafil
Tadalafil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tamsulosin
Tamsulosin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tasimelteon
Tasimelteon may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Technetium Tc-99m exametazime
Technetium Tc-99m exametazime may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Technetium Tc-99m pyrophosphate
Technetium Tc-99m pyrophosphate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Teduglutide
Teduglutide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Telavancin
Telavancin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Temazepam
Temazepam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tenofovir disoproxil
Tenofovir disoproxil may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Terbutaline
Terbutaline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Testosterone propionate
Testosterone propionate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Testosterone undecanoate
Baricitinib may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
Tetradecyl hydrogen sulfate (ester)
Tetradecyl hydrogen sulfate (ester) may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Ticlopidine
Ticlopidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Timolol
Timolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tinidazole
Tinidazole may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tiopronin
Tiopronin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tiotropium
Tiotropium may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tirofiban
Tirofiban may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tocopherol
Tocopherol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tolazamide
Tolazamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tolcapone
Tolcapone may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tolmetin
Tolmetin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tolterodine
Tolterodine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Tolvaptan
Tolvaptan may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Topiramate
Topiramate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Torasemide
Torasemide may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy.
Tramadol
Tramadol may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Trametinib
Trametinib may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Triamterene
Triamterene may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Triazolam
Triazolam may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Triethylenetetramine
Triethylenetetramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Trimethoprim
Trimethoprim may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Trimetrexate
Trimetrexate may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Vaborbactam
Baricitinib may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
Valaciclovir
Valaciclovir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Valbenazine
Baricitinib may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Valdecoxib
Valdecoxib may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Valganciclovir
Valganciclovir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Varenicline
Varenicline may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Venlafaxine
Venlafaxine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Viloxazine
The metabolism of Baricitinib can be decreased when combined with Viloxazine.
Vortioxetine
Vortioxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Zaleplon
Zaleplon may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Zanamivir
Zanamivir may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Zonisamide
Zonisamide may decrease the excretion rate of Baricitinib which could result in a higher serum level.